[TLX] QoQ Quarter Result on 31-Dec-2021 [#Q4]

Stock
[TLX] Telix Pharmaceuticals Limited
Announcement Date
30-Dec-2021
Financial Year
2021
Quarter
31-Dec-2021 [#Q4]
Profit Trend
QoQ- -47.62%
YoY- -80.53%
Quarter Report
TLX's Result
TLX's Financial Summary
View:
Show?
Quarter Result
30/06/23 31/12/22 30/06/22 31/12/21 30/06/21 31/12/20 30/06/20 CAGR
Revenue 220,834 136,049 24,047 4,686 2,910 3,606 1,607 416.03%
PBT -12,300 -27,919 -70,703 -61,993 -37,046 -35,157 -25,096 -21.15%
Tax 2,020 5,269 188 -13,997 -4,532 -8,571 -6,795 -
NP -14,320 -33,188 -70,891 -47,996 -32,514 -26,586 -18,301 -7.85%
Tax Rate - - - - - - - -
Total Cost 235,154 169,237 94,938 52,682 35,424 30,192 19,908 127.74%
Ratio Analysis
30/06/23 31/12/22 30/06/22 31/12/21 30/06/21 31/12/20 30/06/20 CAGR
NP Margin -6.48 -24.39 -294.80 -1,024.24 -1,117.32 -737.27 -1,138.83 -82.14%
Per Share
30/06/23 31/12/22 30/06/22 31/12/21 30/06/21 31/12/20 30/06/20 CAGR
EPS -0.05 -0.10 -0.23 -0.17 -0.12 -0.10 -0.07 -10.60%
EPS Diluted -0.05 -0.10 -0.23 -0.17 -0.12 -0.10 -0.07 -10.60%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.